UPDATE: Garmin (GRMN) to replace RR Donnelly in S&P 500
Tweet
Share
E-mailGet Alerts GRMN Hot Sheet
Join SI Premium – FREE
(Updated - December 5, 2012 5:22 PM EST)
Garmin (NASDAQ: GRMN) to replace RR Donnelley (NASDAQ: RRD) in S&P 500 and RR Donnelley will replace Medicis Pharmaceutical Corp. (NYSE: MRX) in the S&P MidCap 400 after the close of trading Tuesday, December 11.
Valeant Pharmaceuticals International Inc. (NYSE:VRX) is acquiring Medicis.
Garmin (NASDAQ: GRMN) to replace RR Donnelley (NASDAQ: RRD) in S&P 500 and RR Donnelley will replace Medicis Pharmaceutical Corp. (NYSE: MRX) in the S&P MidCap 400 after the close of trading Tuesday, December 11.
Valeant Pharmaceuticals International Inc. (NYSE:VRX) is acquiring Medicis.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lowe's (LOW) PT Lowered to $275 at Guggenheim
- Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings
- BofA says CTA Treasury shorts stable, euro short-cover risk rises
Create E-mail Alert Related Categories
Trader TalkRelated Entities
Standard & Poor'sSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
